Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2022 | The management of elderly patients with CLL

Christine Ryan • 10 Jun 2022
EHA 2022
Chronic Lymphocytic Leukemia Leukemia

Christine Ryan, MD, Dana-Farber Cancer Institute, Boston, MA, comments on the management of elderly patients with chronic lymphocytic leukemia (CLL). This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.

More from Christine Ryan

1:01
Exciting advances in the field of CLL
Christine Ryan • 10 Jun 2022
2:58
Results of a Phase Ib study of ibrutinib + obinutuzumab in R/R CLL
Christine Ryan • 10 Jun 2022

Related Videos

2:06
Managing relapsed ALL: the role of novel cellular therapies & importance of conditioning regimens
Christina Peters • 15 Apr 2024
1:14
Promising novel agents in AML: menin inhibitors
Mark Levis • 16 Apr 2024
3:02
EUPLAGIA-1: Phase I trial of GLPG5201, a CD19 CAR-T product, in R/R CLL and Richter's transformation
Valentin Ortiz-Maldonado • 16 Apr 2024
1:48
Do all patients require maintenance therapy following alloSCT?
Mark Levis • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals